Last month, the FDA gave approval to a new product used in sclerotherapy, the cosmetic treatment of unsightly veins. Asclera, also known as polidocanol, is injected into the vein, which causes damage to the cell lining and closure of the vein.
“Asclera is indicated for the treatment of small types of varicose veins when the aim of treatment is to improve appearance,” said Dr. Norman Stockbridge of the FDA’s Center for Drug Evaluation and Research.
According to FDA.gov, approval for Asclera is indicated for
- Spider veins (tiny varicose veins less than 1 millimeter in diameter)
- Reticular veins (those that are 1 to 3 millimeters in diameter)
The drug is also said to include an anesthetic for more comfortable vein treatment. Learn more about sclerotherapy at Skin Speaks Spa.
